tm logo

Monitor this mark

View On USPTO

DDR
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 04 Dec 2020

Last Applicant/ Owned by

Takeda Pharmaceuticals U.S.A., Inc

One Takeda Parkway

Deerfield

IL

60015

Serial Number

85827887 filed on 21st Jan 2013

Registration Number

4520074 registered on 29th Apr 2014

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq.

c/o IP Services NYC

875 Third Avenue

New York NY 10022

Filing Basis

1. use application currently

Disclaimer

NO DATA

DDR

Modified release drug delivery formulation which is sold as an integral component of pharmaceutical preparations for the treatment of gastrointestinal diseases

Classification Information

Class [005]
Pharmaceutical Products

Modified release drug delivery formulation which is sold as an integral component of pharmaceutical preparations for the treatment of gastrointestinal diseases

First Use Date in General

01st Feb 2009

First Use Date in Commerce

01st Feb 2009

Mark Details

Serial Number

No 85827887

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 255546000009

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
04th Dec 2020CANCELLED SEC. 8 (6-YR)
20th May 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
20th May 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Mar 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13th Mar 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
13th Mar 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13th Mar 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
13th Mar 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
13th Mar 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Aug 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED